Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert H Getzenberg

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
Journal of Cellular Biochemistry|April 6, 2011
Resistance to paclitaxel increases the sensitivity to other microenvironmental stresses in prostate cancer cellsYouqiang Li, Yu Zeng, Steven M Mooney, et al.
The Prostate|May 7, 2009
Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2Eddy S Leman, Ahmed Magheli, Grant W Cannon, et al.
Cancer Research|August 28, 2003
The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell linesMasaaki Kasai, Jennifer Guerrero-Santoro, Robert Friedman, et al.
Urology|October 19, 2005
Efficacy of BTA stat, cytology, and survivin in bladder cancer surveillance over 5 years in patients with spinal cord injuryBenjamin Davies, Joseph J Chen, Timothy McMurry, et al.
Urology|December 20, 2005
Highly specific urine-based marker of bladder cancerThu-Suong Van Le, Raymond Miller, Timothy Barder, et al.
Journal of Cellular Biochemistry|October 2, 2009
Identification of nuclear structural protein alterations associated with seminomasEddy S Leman, Ahmed Magheli, Koh Meng Aw Yong, et al.
Endocrinology|February 28, 2004
Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acidShinji Sakamoto, Masahiro Yokoyama, Xianghua Zhang, et al.
The Prostate|November 11, 2009
Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasiaKazutoshi Fujita, Charles M Ewing, Robert H Getzenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancerEddy S Leman, Robert E Schoen, Ahmed Magheli, et al.
Journal of Translational Medicine|September 16, 2011
Cancer/Testis Antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomyTakumi Shiraishi, Naoki Terada, Yu Zeng, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Journal of Cellular Biochemistry|April 6, 2011
Resistance to paclitaxel increases the sensitivity to other microenvironmental stresses in prostate cancer cellsYouqiang Li, Yu Zeng, Steven M Mooney, et al.
The Prostate|May 7, 2009
Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2Eddy S Leman, Ahmed Magheli, Grant W Cannon, et al.
Cancer Research|August 28, 2003
The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell linesMasaaki Kasai, Jennifer Guerrero-Santoro, Robert Friedman, et al.
Urology|October 19, 2005
Efficacy of BTA stat, cytology, and survivin in bladder cancer surveillance over 5 years in patients with spinal cord injuryBenjamin Davies, Joseph J Chen, Timothy McMurry, et al.
Urology|December 20, 2005
Highly specific urine-based marker of bladder cancerThu-Suong Van Le, Raymond Miller, Timothy Barder, et al.
Journal of Cellular Biochemistry|October 2, 2009
Identification of nuclear structural protein alterations associated with seminomasEddy S Leman, Ahmed Magheli, Koh Meng Aw Yong, et al.
Endocrinology|February 28, 2004
Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acidShinji Sakamoto, Masahiro Yokoyama, Xianghua Zhang, et al.
The Prostate|November 11, 2009
Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasiaKazutoshi Fujita, Charles M Ewing, Robert H Getzenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancerEddy S Leman, Robert E Schoen, Ahmed Magheli, et al.
Journal of Translational Medicine|September 16, 2011
Cancer/Testis Antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomyTakumi Shiraishi, Naoki Terada, Yu Zeng, et al.
Pageof 12